# mtDNA as Novel Biomarker for Intra-amniotic Infection

> **NCT03306719** · — · UNKNOWN · sponsor: **Medical University of Vienna** · enrollment: 50 (estimated)

## Conditions studied

- Preterm Premature Rupture of Membrane

## Interventions

- **BIOLOGICAL:** Blood sampling

## Key facts

- **NCT ID:** NCT03306719
- **Lead sponsor:** Medical University of Vienna
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-04-05
- **Primary completion:** 2018-06-30
- **Final completion:** 2018-12-31
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2017-10-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03306719

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03306719, "mtDNA as Novel Biomarker for Intra-amniotic Infection". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03306719. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*